Yuanpei Li

Novel thermo-sensitive core-shell nanoparticles for targeted paclitaxel delivery.

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.

A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.

Maximization of loading and stability of ssDNA:iron oxide nanoparticle complexes formed through electrostatic interaction.

The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.

Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.

PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells.

Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols.

"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.

Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma.

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer.

Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins.

Immobilized OBOC combinatorial bead array to facilitate multiplicative screening.

CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.

Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers.

Telodendrimer-based nanocarriers for the treatment of ovarian cancer.

Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin.

Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling.

A smart and versatile theranostic nanomedicine platform based on nanoporphyrin.

Nanomedicine in veterinary oncology.

In vivo wide-field multispectral scanning laser ophthalmoscopy-optical coherence tomography mouse retinal imager: longitudinal imaging of ganglion cells, microglia, and Müller glia, and mapping of the mouse retinal and choroidal vasculature.

Drosophila eye developmental defect caused by elevation of the activity of the LIM-homeodomain protein, Lmx1a, requires its association with the Co-activator Chip.

HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy.

Developing a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model.

Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer.

Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer.